This article, which originally appeared on the Duke Cancer Institute Blog can only be accessed via The Wayback Machine at this link. Below are screenshots of the original.

In January 2024, Duke University launched a celebration of its centennial — a historic opportunity to recognize Duke’s extraordinary past, communicate the impact of the present, and look toward Duke's potential impact going forward.

Tomi Akinyemiju, PhD, and Katherine Garman, MD, were recognized for their recognized for their equity, diversity, and inclusion work, and Sabino Zani, MD, was recognized as a master clinician/teacher.

For the first time since 2019, the DCI Scientific Retreat was held in person with a full program followed by a poster session and mingling — attracted around 90 faculty, staff, and trainees.

Learn how the Precision Cancer Medicine Initiative, run jointly by DCI and the Duke Dept. of Pathology, is advancing research, extending lives, and breaking down barriers to access.

The Duke BioRepository & Precision Pathology Center grew, thrived, and progressively built a national reputation. “Its success represents the evolution and extension of the Department of Pathology’s support and commitment to cancer research."

DCI oncologists are blazing the trail on the national stage with their inroads in breast and gynecologic cancer research, treatment, and advocacy.

Devon Check, PhD, is co-recipient of a grant from the National Institute on Aging to characterize population-level patterns of opioid and benzodiazepine co-prescribing among older adults with cancer and the risks of avoidable harms.

The DCI 8th Annual Scientific Retreat attracted a broad array of faculty, trainees (students, residents, fellows, postdocs, etc.) and staff. For a second year, the retreat was entirely virtual.

The Southeastern American Indian Cancer Health Equity Partnership seeks to address the stark disparities in cancer health experienced by American Indian communities. NC has the largest American Indian population in the Eastern U.S.

The grants, made possible by the Susan G. Komen Metastatic Breast Cancer Collaborative Research Initiative, have been awarded to teams comprised of patient advocates and DCI and UNC Lineberger Comprehensive Cancer Center investigators.

The annual Presidential Awards program, organized by the Office of the President in partnership with Duke Human Resources, recognizes individuals and teams who best demonstrate the values that define and shape Duke as an institution.

Neelima Navuluri, MD, MPH, has been selected to receive a 2021 NCCN Foundation Young Investigator Award for her project — “Intervention Mapping to Improve Lung Cancer Screening Among Black Veterans." It's an implementation science study.

The Duke-UNC Tobacco Treatment Specialist Training Program has been named Program of the Month (for February) by the Council for Tobacco Treatment Training Programs.

Community outreach and engagement at DCI comes of age; team expands.

DCI's Office of Health Equity — in partnership with city and state public health groups, the Center for Black Equity, and LCI NC — hosts a webinar featuring Jennifer Garst, MD, and patients on the threats of tobacco, radon, and COVID-19 to the lungs.

Who should get screened and what happens if something is found? Here's a primer from DCI experts.

Family physician Kevin Oeffinger, MD — director of the Duke Supportive Care and Survivorship Center and founding director of the Duke Center for Onco-Primary Care — has been named a Fellow of the American Society of Clinical Oncology.

A multi-disciplinary team of researchers have been awarded $100,000 by NCCN and Lilly to optimize gastric and GEJ cancer care.

For 20 years, Nadine Barrett, PhD, has worked to reduce health disparities among underrepresented populations by increasing their access to care and research.